Table 1.
Participant Characteristics
| Participant Characteristic | Patient Sample (N = 122) |
|---|---|
| Demographics | |
| Age in years, M (SD) | 47.0 (9.9) |
| Education in years, M (SD) | 14.2 (4.6) |
| Race, N (%) | |
| Caucasian | 105 (86.1) |
| African American | 14 (11.5) |
| Hispanic | 1 (0.80) |
| Other (not specified) | 2 (1.6) |
| Sex, N (%) | |
| Female | 100 (82.0) |
| Male | 22 (18.0) |
| Clinical Characteristics | |
| First MDD Episode, N (%) | 36 (29.5) |
| Current MDD Episode Length in years, M (SD) | 6.7 (7.9) |
| Age of MDD Onset in years, M (SD) | 27.4 (11.3) |
| Length of Illness in years, M (SD) | 19.8 (11.9) |
| BMI at baseline, M (SD) | 30.8 (6.2) |
| BMI at exit, M (SD) | 30.4 (5.9) |
| SHAPS total at baseline, M (SD) | 3.1 (3.0) |
| SHAPS total at exit, M (SD) | 1.7 (2.5) |
| HRSD17 total at baseline, M (SD) | 18.0 (3.8) |
| HRSD17 total at exit, M (SD) | 11.9 (5.9) |
| IDS-C30 at baseline, M (SD) | 34.0 (7.4) |
| IDS-C30 at exit, M (SD) | 21.9 (11.9) |
| IDS-SR30 at baseline, M (SD) | 32.4 (9.6) |
| IDS-SR30 at exit, M (SD) | 20.6 (11.4) |
| QIDS-C16 at baseline, M (SD) | 13.9 (2.6) |
| QIDS-C16 at exit, M (SD) | 9.4 (4.7) |
| QIDS-SR16 at baseline, M (SD) | 12.6 (4.0) |
| QIDS-SR16 at exit, M (SD) | 8.1 (4.4) |
| IDS-C30 sub-item 21 at baseline, M (SD) | 1.1 (0.91) |
| IDS-C30 sub-item 21 at exit, M (SD) | 0.54 (0.85) |
| IDS-SR30 sub-item 21 at baseline, M (SD) | 1.2 (0.71) |
| IDS-SR30 sub-item 21 at exit, M (SD) | 0.62 (0.69) |
| QLES-Q at baseline, M (SD) | 59.8 (10.7) |
| QLES-Q at exit, M (SD) | 70.0 (12.5) |
Note: M = Mean; SD = Standard Deviation; N = sample size at baseline (n=92 at exit).